Table 6.
NPPV (n = 15) | CMV (n = 15) | P | |
---|---|---|---|
Tracheostomy, n (%) | 0 (0) | 6 (40.0) | 0.008 |
Hospital mortality, n (%) | 3 (20.0) | 7 (46.7) | 0.121 |
Complications, n (%) | 3 (20.0) | 12 (80.0) | 0.001 |
Septic complications, n (%) | 3 (20.0) | 9 (60.0) | 0.025 |
Sepsis and septic shock, n (%) | 1 (6.7) | 5 (33.3) | 0.169 |
Nosocomial pneumonia, n (%) | 2 (13.3) | 4 (26.7) | 0.651 |
Non-septic complications, n (%) | 0 (0) | 3 (20.0) | 0.224 |
Cardiovascular complications, n (%) | 0 (0) | 1 (6.7) | 1.000 |
Acute renal failure, n (%) | 0 (0) | 1 (6.7) | 1.000 |
Gastrointestinal bleeding, n (%) | 0 (0) | 1 (6.7) | 1.000 |
MV length, days median (IQR) | 9 (5-12)a | 17 (7-27)b | 0.270 |
Length of hospitalisation, days mean (SD) | 20 (4)a | 27 (21)b | 0.423 |
IQR, interquartile range; MV, mechanical ventilation; SD, standard deviation.
aNPPV patients who avoided endotracheal intubation (n = 12).
b CMV patients who survived to discharge (n = 8).